30‐day mortality* · people admitted to intensive care units
It is very uncertain whether automated monitoring systems changes 30‐day mortality* compared with standard care (very low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Duration of ICU stay · people admitted to intensive care units
1 finding from 1 review
Artificial airway occlusion (measured over 3‐15 days (median 4 days)) · ventilated adults (18 trials) and children (1 trial)
Heat and moisture exchangers (HME) showed no clear difference in artificial airway occlusion (measured over 3‐15 days (median 4 days)) compared with heated humidifiers (HH) (low certainty).
1 finding from 1 review
All‐cause mortality, over the course of the study · ventilated adults (18 trials) and children (1 trial)
Heat and moisture exchangers (HME) showed no clear difference in mortality ‐ all cause (Measured over 3‐15 days (median 8 days)) compared with heated humidifiers (HH) (low certainty).
1 finding from 1 review
Pneumonia · ventilated adults (18 trials) and children (1 trial)
Heat and moisture exchangers (HME) showed no clear difference in pneumonia (Measured over 4‐21 days (median 4 days)) compared with heated humidifiers (HH) (low certainty).
1 finding from 1 review
28‐Day mortality · patients with sepsis
Should high‐volume haemofiltration showed no clear difference in 28‐Day mortality compared with standard or usual dialysis be used (low certainty).
1 finding from 1 review
Mortality at 28 days · adult patients with sepsis, severe sepsis and septic shock
PCT showed no clear difference in mortality at 28 days compared with non‐PCT (standard care or CRP: primary outcomes) (low certainty).
1 finding from 1 review
Time receiving antimicrobial therapy (days) ‐ mean (SD) · adult patients with sepsis, severe sepsis and septic shock
1 finding from 1 review
Overall mortality at 28 days · critically ill participants with ALI and ARDS
INO showed no clear difference in overall mortality at 28 days compared with control group (moderate certainty).
1 finding from 1 review
Ventilator‐free days up to day 28 · critically ill participants with ALI and ARDS
INO showed no clear difference in ventilation‐free days, up to 30 days compared with control group (high certainty).
1 finding from 1 review
Mortality (at 30 days or until hospital discharge) · people with Acute Respiratory Distress Syndrome
It is very uncertain whether high‐frequency oscillation changes mortality (at 30 days or until hospital discharge) compared with conventional ventilation (very low certainty).
1 finding from 1 review
Duration of mechanical ventilation · people with Acute Respiratory Distress Syndrome
1 finding from 1 review
Intervention not reported
Ventilator days · children with critical illness
It is very uncertain whether the intervention changes ventilator days (very low certainty).
1 finding from 1 review
Intervention not reported
Length of stay (days) · children with critical illness
It is very uncertain whether the intervention changes length of stay (days) (very low certainty).
1 finding from 1 review
Intervention not reported
28‐Day mortality · mechanically ventilated adults with acute respiratory distress syndrome. Participants were recruited from ICUs internationally, including…
The intervention showed no clear difference in 28‐Day mortality (low certainty).
1 finding from 1 review
Intervention not reported
Days on ventilator (selenium) · Patients with critical illnesses
It is very uncertain whether the intervention changes days on ventilator (selenium) (very low certainty).
1 finding from 1 review
Ventilator‐free days up to day 28 · critically ill patients
1 finding from 1 review
Days of MV during 1 to 60 days · critically ill patients
1 finding from 1 review
ICU discharge (at day 28 after randomization) · critically ill patients
Early leads to higher ICU discharge (at day 28 after randomization) compared with late tracheostomy (high certainty).
1 finding from 1 review
Duration of mechanical ventilation · critically ill adult patients
1 finding from 1 review